Literature DB >> 16313963

The prevalence of HCV antibody in South Australian prisoners.

E R Miller1, P Bi, P Ryan.   

Abstract

OBJECTIVES: The study was aimed at identifying the hepatitis C virus (HCV)-antibody status of prisoners incarcerated in South Australia in order to develop an HCV prevalence estimate for the whole prison system.
METHODS: The health records of persons incarcerated within eight prisons (accommodating approximately 93% of the jurisdiction's adult incarcerated population) were audited for evidence of HCV infection, age, sex, Indigenous status (Australian Aboriginal or Torres Strait Islander) and date of entry to prison. These data were analysed using both univariate and multivariate techniques.
RESULTS: Among 1347 prisoners (1254 males and 93 females), 30.2% were HCV-antibody positive. After excluding those with no history of testing, HCV-antibody prevalence rose to 41.3% (males 39.8%, females 66.1%). HCV-antibody positivity was significantly associated with age, sex and Indigenous status in both univariate and multivariate analyses.
CONCLUSIONS: Consistent with the literature, the prevalence of HCV infection in the SA prison system appears to be extremely high. This study suggests that HCV prevention efforts in prison settings should be considered as an important priority.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313963     DOI: 10.1016/j.jinf.2005.10.014

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

1.  Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil.

Authors:  Bruno Fernandes de Oliveira Santos; Nathalie Oliveira de Santana; Alex Vianey Callado Franca
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

2.  Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.

Authors:  Marisol Peña-Orellana; Adriana Hernández-Viver; Glorimar Caraballo-Correa; Carmen E Albizu-García
Journal:  J Health Care Poor Underserved       Date:  2011-08

3.  Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Niloofar Darvishi; Mahvan Hemmati; Shamarina Shohaimi; Yasaman Ghyasi; Farahnaz Hossaini; Mohammad-Rafi Bazrafshan; Hakimeh Akbari; Masoud Mohammadi
Journal:  Arch Virol       Date:  2022-02-14       Impact factor: 2.574

4.  Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.

Authors:  Kathryn J Snow; Jesse T Young; David B Preen; Nicholas G Lennox; Stuart A Kinner
Journal:  BMC Public Health       Date:  2014-08-11       Impact factor: 3.295

5.  Testing for sexually transmitted infections and blood borne viruses on admission to Western Australian prisons.

Authors:  Rochelle E Watkins; Donna B Mak; Crystal Connelly
Journal:  BMC Public Health       Date:  2009-10-13       Impact factor: 3.295

6.  Hepatitis B and Hepatitis C Viral Infections and Associated Factors Among Prisoners in Northeast Ethiopia.

Authors:  Yeshimebet Kassa; Yihenew Million; Sirak Biset; Feleke Moges
Journal:  J Blood Med       Date:  2021-07-05

7.  Viral hepatitis in correctional facilities in the Northern Territory of Australia 2003-2017.

Authors:  Richard P Sullivan; Rob Baird; Kevin Freeman; Hugh Heggie; Joshua S Davis; Catherine S Marshall; Jane Davies
Journal:  BMC Infect Dis       Date:  2021-06-16       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.